Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Articles
  3. liver fibrosis
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Videos

Refine by
Date

  • Older

Liver Fibrosis Articles & Analysis

14 articles found

CCR1 Protein: A Chemokine Receptor at the Crossroads of Immunity and Disease

CCR1 Protein: A Chemokine Receptor at the Crossroads of Immunity and Disease

Tumor-associated fibroblasts and macrophages often express CCR1, where they help establish pro-tumor niches by promoting angiogenesis and suppressing anti-tumor immunity. In liver metastases, CCR1 signaling has been implicated in preparing pre-metastatic niches. ...

ByCreative BioMart


Glycan Cartography Mapping the Uncharted Territories of Cell Communication   

Glycan Cartography Mapping the Uncharted Territories of Cell Communication  

Alterations in serum N-glycan profiles now serve as early detection biomarkers for liver fibrosis, outperforming traditional markers. Meanwhile, aberrant O-glycosylation in mucins creates the CA125 epitope used to monitor ovarian cancer progression. ...

ByCreative Proteomics


Preclinical Models of Non-Alcoholic Fatty Liver Disease

Preclinical Models of Non-Alcoholic Fatty Liver Disease

Such models allow for controlled studies in vitro, facilitating the examination of cellular mechanisms, lipid metabolism, and the effects of specific compounds on liver cells. They serve as an excellent tool for screening potential drugs or understanding the effects of dietary components on liver health. ...

ByCreative Bioarray


Development of mRNA-Directed Delivery - LNP Delivery System

Development of mRNA-Directed Delivery - LNP Delivery System

These mRNA-loaded LNPs deliver specific mRNA to the liver for the treatment of various liver-related diseases, including infectious diseases, liver fibrosis, cancer, and genetic disorders. 2) Spleen or lung targeting LNP: Researchers at the University of Texas Southwestern Medical Center reported that selective organ targeting ...

ByBOC Sciences


Cell Transplantation Promising for Treatment of Biliary Diseases   

Cell Transplantation Promising for Treatment of Biliary Diseases  

Biliary disease is a term used to describe diseases that affect the biliary system, which can result in inflammation, fibrosis, bile duct destruction, and eventually liver failure. It also frequently leads to secondary infections and chronic irritation, such as bile duct stones, which can lead to malignant tumors. ...

ByCreative Biolabs


Changes in MRE in HCV patients who achieve SVR

Changes in MRE in HCV patients who achieve SVR

A total of 44% of patients had no improvement in liver stiffness despite achieving SVR. In patients with advanced fibrosis (lower level of albumin [Alb] or histological fibrosis stage F4), it was difficult to improve liver stiffness. Except for Alb, there were no blood tests associated with nonimprovement in ...

ByResoundant, Inc.


The Role of Probiotics in Cancer Prevention Receives Increasing Attention

The Role of Probiotics in Cancer Prevention Receives Increasing Attention

These risk factors can easily lead to liver damage, which subsequently develops into liver fibrosis, cirrhosis and eventually liver cancer. ...

ByCreative Enzymes


MRE associated with increased risk of cardiovascular disease in patients with NAFLD - Case study

MRE associated with increased risk of cardiovascular disease in patients with NAFLD - Case study

This important study of MRE and long term cardiovascular outcomes adds a new dimension to the growing body of literature that elevated liver stiffness is not only correlated with increased liver fibrosis and adverse liver-related events, but is tied to adverse systemic events as well. To read the full study: ...

ByResoundant, Inc.


Improved 3D Liver Model Could Forever Change Drug Testing – Allevi Author

Improved 3D Liver Model Could Forever Change Drug Testing – Allevi Author

The liver plays an incredibly important role in the human body by metabolizing drugs and other compounds. ...

ByAllevi, Inc.


Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD

Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD

Furthermore, stool bile acids and propionate are elevated, especially in non-obese subjects with significant fibrosis. Fibrosis-relatedRuminococcaceaeandVeillonellaceaespecies undergo metagenome sequencing, and four representative species are administered in three mouse NAFLD models to evaluate their effects on liver damage. This study provides ...

ByKoBioLabs


Degradation of splicing factor SRSF3 contributes to progressive liver disease

Degradation of splicing factor SRSF3 contributes to progressive liver disease

Abstract Serine-rich splicing factor 3 (SRSF3) plays a critical role in liver function and its loss promotes chronic liver damage and regeneration. ...

ByJohnson Controls, Inc.


	 Utilization of a 3D bioprinted liver tissue model to evaluate the antifibrotic effects of an ALK5 inhibitor in a TGFß-induced model of hepatic fibrosis

Utilization of a 3D bioprinted liver tissue model to evaluate the antifibrotic effects of an ALK5 inhibitor in a TGFß-induced model of hepatic fibrosis

Evaluation of potential antifibrotic therapies are limited using conventional non-human animal models, due to their inability to accurately reflect complex in vivo human biology, while 2D models lack the multicellular complexity and life span required to study fibrosis progression and regression. Utilization of a human 3D-bioprinted liver tissue model ...

ByOrganovo Holdings Inc.


Overview Of SFA Therapeutics

Overview Of SFA Therapeutics

SFA Therapeutics’ CEO Dr Ira Spector presents an overview of the company and its platform technology SFA Overview Presentation on YouTube Introduction to SFA Liver Disease and Oncology Programs. SFA Oncology More information here We received US Patent 10,143,669B2; to prevent Hepatitis B progression to HCC, a liver cancer that affects 400 million ...

BySFA Therapeutics, Inc.


Liver function assessment in workers exposed to vinyl chloride

Liver function assessment in workers exposed to vinyl chloride

Methods: A medical examination including the execution of liver function tests (LFTs) and liver ultrasonography was executed in a group of 757 workers with a long-standing service in the production of VCM/polyvinylchloride (PVC). ...

BySpringer-Verlag GmbH

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT